Cargando…

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA

BACKGROUND: Voluntary non-remunerated repeat blood donors are perceived to be safer than the first time blood donors. This study was planned for follow-up of previous hepatitis C virus (HCV) test results of anti-HCV enzyme-linked immunosorbent assay (ELISA) reactive repeat blood donors. The aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, N., Tulsiani, Sunita, Desai, Priti, Shah, Ripal, Mathur, Ankit, Harimoorthy, V.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082711/
https://www.ncbi.nlm.nih.gov/pubmed/21572711
http://dx.doi.org/10.4103/0973-6247.75979
_version_ 1782202317687226368
author Choudhury, N.
Tulsiani, Sunita
Desai, Priti
Shah, Ripal
Mathur, Ankit
Harimoorthy, V.
author_facet Choudhury, N.
Tulsiani, Sunita
Desai, Priti
Shah, Ripal
Mathur, Ankit
Harimoorthy, V.
author_sort Choudhury, N.
collection PubMed
description BACKGROUND: Voluntary non-remunerated repeat blood donors are perceived to be safer than the first time blood donors. This study was planned for follow-up of previous hepatitis C virus (HCV) test results of anti-HCV enzyme-linked immunosorbent assay (ELISA) reactive repeat blood donors. The aim was to suggest a protocol for re-entry of the blood donors who are confirmed HCV negative by nucleic acid test (NAT) and recombinant immunoblot assay (RIBA). A group of repeat voluntary donors were followed retrospectively who became reactive on a cross sectional study and showed HCV reactivity while donating blood regularly. MATERIAL AND METHODS: A total of 51,023 voluntary non remunerated blood donors were screened for anti-HCV ELISA routinely. If anybody showed positivity, they were tested by two ELISA kits (screening and confirmatory) and then confirmed infection status by NAT and or RIBA. The previous HCV test results of repeat donors reactive by anti-HCV ELISA were looked back from the records. Data of donors who were repeat reactive with single ELISA kit (in the present study) were analyzed separately from those reactive with two ELISA kits (in the present study). RESULTS: In this study, 140 (0.27%) donors who were reactive by anti HCV ELISA were included. Out of them, 35 were repeat voluntary donors and 16 (11.43%) were reactive with single ELISA kit. All 16 donors were reactive by single ELISA kit occasionally in previous donations. Their present ELISA positive donations were negative for HCV NAT and RIBA. A total of 19 (13.57%) donors were reactive with two ELISA kits. In their previous donations, the donors who were reactive even once with two ELISA kits were consistently reactive by the same two ELISA kits in their next donations also. CONCLUSION: Donor sample reactive by only single ELISA kit may not be considered as infectious for disposal as they were negative by NAT and or RIBA. One time ELISA positivity was found probably due to ELISA kit specificity and sensitivity. Donors reactive with two ELISA kit should be discarded as there is a high positivity with NAT/ RIBA. However, donors reactive by two ELISA kits and negative by NAT and RIBA should be followed up and may not be deferred permanently.
format Text
id pubmed-3082711
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30827112011-05-13 Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA Choudhury, N. Tulsiani, Sunita Desai, Priti Shah, Ripal Mathur, Ankit Harimoorthy, V. Asian J Transfus Sci Original Article BACKGROUND: Voluntary non-remunerated repeat blood donors are perceived to be safer than the first time blood donors. This study was planned for follow-up of previous hepatitis C virus (HCV) test results of anti-HCV enzyme-linked immunosorbent assay (ELISA) reactive repeat blood donors. The aim was to suggest a protocol for re-entry of the blood donors who are confirmed HCV negative by nucleic acid test (NAT) and recombinant immunoblot assay (RIBA). A group of repeat voluntary donors were followed retrospectively who became reactive on a cross sectional study and showed HCV reactivity while donating blood regularly. MATERIAL AND METHODS: A total of 51,023 voluntary non remunerated blood donors were screened for anti-HCV ELISA routinely. If anybody showed positivity, they were tested by two ELISA kits (screening and confirmatory) and then confirmed infection status by NAT and or RIBA. The previous HCV test results of repeat donors reactive by anti-HCV ELISA were looked back from the records. Data of donors who were repeat reactive with single ELISA kit (in the present study) were analyzed separately from those reactive with two ELISA kits (in the present study). RESULTS: In this study, 140 (0.27%) donors who were reactive by anti HCV ELISA were included. Out of them, 35 were repeat voluntary donors and 16 (11.43%) were reactive with single ELISA kit. All 16 donors were reactive by single ELISA kit occasionally in previous donations. Their present ELISA positive donations were negative for HCV NAT and RIBA. A total of 19 (13.57%) donors were reactive with two ELISA kits. In their previous donations, the donors who were reactive even once with two ELISA kits were consistently reactive by the same two ELISA kits in their next donations also. CONCLUSION: Donor sample reactive by only single ELISA kit may not be considered as infectious for disposal as they were negative by NAT and or RIBA. One time ELISA positivity was found probably due to ELISA kit specificity and sensitivity. Donors reactive with two ELISA kit should be discarded as there is a high positivity with NAT/ RIBA. However, donors reactive by two ELISA kits and negative by NAT and RIBA should be followed up and may not be deferred permanently. Medknow Publications 2011-01 /pmc/articles/PMC3082711/ /pubmed/21572711 http://dx.doi.org/10.4103/0973-6247.75979 Text en © Asian Journal of Transfusion Science http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Choudhury, N.
Tulsiani, Sunita
Desai, Priti
Shah, Ripal
Mathur, Ankit
Harimoorthy, V.
Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA
title Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA
title_full Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA
title_fullStr Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA
title_full_unstemmed Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA
title_short Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA
title_sort serial follow-up of repeat voluntary blood donors reactive for anti-hcv elisa
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082711/
https://www.ncbi.nlm.nih.gov/pubmed/21572711
http://dx.doi.org/10.4103/0973-6247.75979
work_keys_str_mv AT choudhuryn serialfollowupofrepeatvoluntaryblooddonorsreactiveforantihcvelisa
AT tulsianisunita serialfollowupofrepeatvoluntaryblooddonorsreactiveforantihcvelisa
AT desaipriti serialfollowupofrepeatvoluntaryblooddonorsreactiveforantihcvelisa
AT shahripal serialfollowupofrepeatvoluntaryblooddonorsreactiveforantihcvelisa
AT mathurankit serialfollowupofrepeatvoluntaryblooddonorsreactiveforantihcvelisa
AT harimoorthyv serialfollowupofrepeatvoluntaryblooddonorsreactiveforantihcvelisa